58 min listen
Key Studies Influencing My Practice Following EACS 2021—Audio Recap
Key Studies Influencing My Practice Following EACS 2021—Audio Recap
ratings:
Length:
36 minutes
Released:
Nov 30, 2021
Format:
Podcast episode
Description
In this episode, Tristan J. Barber, MA, MD, FRCP, discusses new HIV data from EACS 2021, including:First-line therapiesBIC/FTC/TAF in a test-and-treat model in IMEA 055 FASTWeek 144 data of ISL + DOR in treatment-naive patients from P011Switch StrategiesData on the use of DTG/3TC in patients with an M184V mutation from SOLAR 3D and the French Dat’AIDS CohortLong-Acting TherapiesEfficacy and safety of LA CAB + RPV by BMILong-term follow-up of participants who discontinued LA CAB + RPV in the ATLAS, ATLAS-2M, and FLAIR trialsPatient satisfaction with LA CAB + RPV from the CARISEL studyResistance and subgroup data from the CAPELLA study of lenacapavir in heavily treatment–experienced patientsCOVID-19 vaccination efficacy and the impact of the pandemic on viral suppression in PWHPresenter:Tristan J. Barber, MA, MD, FRCPConsultant in HIV MedicineIan Charleson Day CentreRoyal Free HospitalHonorary Associate ProfessorInstitute for Global HealthUniversity College LondonLondon, United KingdomContent based on a CME program supported by educational grants from Gilead Sciences, Inc.; Merck Sharp & Dohme Corp; and ViiV Healthcare.Follow along with an expanded slideset at:https://bit.ly/32RCX4NLink to full program:https://bit.ly/3G2GknK
Released:
Nov 30, 2021
Format:
Podcast episode
Titles in the series (100)
Virtual ECCVID 2020 Conference – Rapid Recap: Hear insights from Barbara Rath, MD, PhD, HDR, on some of the most important new data reported at the 2020 European Society of Clinical Microbiology and Infectious Diseases Conference on Corona Virus Disease (ECCVID), including information on COVID-19 screening and diagnostics, vaccines, prevention strategies, and therapeutics. by CCO Infectious Disease Podcast